Treatment of chronic myeloid leukemia in childhood - Proposal for a multicenter pilot protocol 'CML-pad';DIE BEHANDLUNG DER CHRONISCH MYELOISCHEN LEUKAMIE (CML) BEI KINDERN UND JUGENDLICHEN - KONZEPT DER MULTIZENTRISCHEN PILOTSTUDIE CML-PAD

Klinische Padiatrie

Volumn 208, Issue 4, 1996, Pages 242-249

  Suttorp, Meinolf ^a   Lion, Thomas ^b   Creutzig, Ursula ^c   Klingebiel, Thomas ^d   Gadner, Helmut ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CML in childhood

Indexed keywords

ALPHA INTERFERON; CYCLOPHOSPHAMIDE; CYTARABINE; HYDROXYUREA; IDARUBICIN; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; CHILDHOOD DISEASE; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE ACTIVITY; HUMAN; MOLECULAR BIOLOGY; REVIEW;

EID: 0030037624     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1046480     Document Type: Review

References (62)

1. Allan, N. C., S.-M. Richards, P. C. A. Shepherd: UK Medical Research Council randomized, multicentre trial of interferon-alpha for chronic myeloid leukemia: improved survival irrespective of cytogenetic response. Lancet 345 (1995) 1392-1397
2. Altman, A. J.: Chronic leukemias of childhood. In: Pizzo, P. A., D. G. Poplack (eds): Pediatric Oncology, J. B. Lippincot. Philadelphia, USA 1990, pp 383-396
3. Arcese W., J. M. Goldman, E. D'Arcangelo, et al.: Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Blood 82 (1993) 3211-3219
4. Aulitzky, W. E., C. Peschl, D. Despres, et al.: Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia. Ann. Hematol. 67 (1993) 205-211
5. Aulitzky, W. E., C. Peschl, F. Schneller, et al.: Biotherapy of chronic myelogenous leukemia. Ann. Hematol. 70 (1995) 113-120
6. Bartram, C. R., A. de Klein, A. Hagemeijer, et al.: Translocation of the c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia. Nature 306 (1983) 277-380
7. Bartram, C. R.: Rearrangement of the c-abl and bcr-genes in Ph-negative CML and Ph-positive acute Leukemias. Leukemia 2 (1988) 63-64
8. Biernaux, C., M. Loss, A. Sels, G. Huez, P. Stryckmans: Detection of major bcr-abl gene expresssion at a very low level in blood cells of some healthy individuals. Blood 86 (1995) 3118-3122
9. Bortin, M. M., M. M. Horowitz, P. A. Rowlings, et al.: 1993 progress report from the international bone marrow transplant registry. Bone Marrow Transplant. 12 (1993) 97-104
10. Butturini, A., A. Keating, J. M. Goldman et al.: Autotransplants in chronic myelogenous leukaemia: strategies and results. Lancet 335 (1990) 1255-1258
11. Carella, A. M., M. Podesta, F. Frassoni, M. R. Raffo, M. Pollicardo, et al.: Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant. 12 (1993) 267-271
12. Castro-Malaspina, H., G. Schaison, J. Briere, et al.: Philadelphia chromosome-positive chronic myelocytic leukemia in children. Survival and prognostic features. Cancer 52 (1983) 721-727
13. Chalmers, E. A., I. M. Franklin, S. Kelsey, et al.: Mobilisation of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine. Bone Marrow Transplant. 14 (Suppl 3) (1994) S38-S41
14. Clift, R. A., C. D. Buckner, C. D. Thomas, et al.: Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia. Blood 84 (1994) 4368-4373
15. Cornish, J., M. N. Potter, C. G. Steward et al.: Unrelated donor hone marrow transplant for acute lymphoblastic leukemia in childhood. (Abstract) Blood 86 (Suppl. 1) (1995) 382a
16. Creutzig, U., J. Ritter, T. Klingebiel: Prognose der chronischen myeloischen Leukämie im Kindesalter: Eine retrospektive Analyse von 78 Patienten. (Abstract) Monatschr. Kinderheilkd. 143 (1995) 1158
17. Cross, N. C. P., L. Feng, A. Chase, et al.: Competitive polymerase chain reaction to estimate the number of bcr-abl transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82 (1993) 1929-1936
18. Dexter, T.M., J. Chang: New strategies for the treatment of chronic myeloid leukemia. Blood 84 (1994) 673-675
19. Dow, L. W., S. C. Raimondi, S. J. Culbert, J. Ochs, et al.: Response to alpha-interferon in children with Philadelphia chromosome-positive chronic myelocytic leukemia. Cancer 68 (1991) 1678-1684
20. Fialkow, P. J.: Clonal evolution of human mycloid leukemias. In: Bishop, J. M., J. D. Rowley, M. Greaves (eds.); Genes and Cancer, Liss, A. R., New York, USA (1984); pp 215-226
21. Franklin, I. M., E., A. Chalmers, S. M. Kelsey, et al.: Philadelphia negative PBSC mobilisation in chronic phase CML following Idarubicin and Cytarabine therapy. (Abstract) J. Hematother. 4. (1995) 201
22. Friedrich, W., S. Müller, M. Schreiner, et al.: The combined use of positively selected, T-cell depleted blood stem cells with bone marrow in HLA non-identical bone marrow transplantation: a pilot study in childhood leukemia. (Abstract) J. Hematother. 4 (1995) 200
23. Gamis, A. S., R. Haake, P. McGlave, et al.: Unrelated donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children. J. Clin. Oncol. 11 (1993) 834-838
24. Goldman, J. M., R. Szydio, M. M. Horowitz, et al.: Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase. Blood 82 (1993) 2235-2238
25. Goldman, J. M.: Management of chronic myeloid leukemia. Blood Reviews 8 (1994) 21-29
26. Gordon, M. Y.: Cell biology of CML - a model linking the chronic and terminal phases. Leukemia Lymphoma 11 (Suppl. 1) (1993) 93-100
27. Hehlmann, R.: Cytostatic therapy in chronic myelogenous leukemia: Review and perspectives. In: Huhn, D., K. P. Hellriegel, N. Niederle (eds.): Chronic myelocytic leukemia and interferon. Springer Verlag, Berlin, 102-112 (1988)
28. Hehlmann, R., H. Heimpel, B. Heinze, et al.: Multizentrische prospektive kontrollierte Studie zur Therapie der chronisch myeloischen Leukämie. Vergleich von Busulfan, Hydroxyurea und Interferon alpha (Stand April 1990). Onkologie 14 (1991) 66-73
29. Hehlmann, R., H. Heimpel, J. Hasford, et al.: Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia (CML): prolongation of survival by hydroxyurea. Blood 82 (1993) 398-407
30. Hehlmann, R., H. Heimpel, J. Hasford, et al.: Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 84 (1994) 4064-4077
31. Hehlmann, R., H. Heimpel, D. K. Hossfeld, et al.: Prospektiv kontrollierte Studie zur Therapie der chronischen myeloischen Leukämie (CML III). III. Med. Klinik. Klinikum Mannheim. Wiesbadenerstr. 7-11, 63305 Mannheim: Mannheim 1995
32. Herrmann, F., D. Jonas, S. D. Helfrich, et al.: Interferon alpha-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic, and molecular-genetic response of patients with chronic phase previously resistant to therapy with interferon gamma. Blut 61 (1990) 226-231
33. Hertenstein, B. M. Wiesneth, J. Novotny, et al.: Interteron-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation 56 (1993) 1114-1118
34. Holyoake, T. L., M. Freshney, A. M. Sproul, et al.: Contrasting effects of rh-MIP-1a and TGF-b1 on chronic myeloid leukaemia progenitors in vitro. Stem Cells 12 (1994) 114-124
35. Homans, A. C., P. C. Young, J. D. Dickerman, et al.: Adult-type CML in childhood: case report and review. Am. J. Pediatr. Hematol. Oncol. 6 (1984) 220-224
36. Hook, E. B.: Exclusion of chromosomal mosaicism: Tables of 90%, 95%, and 99% confidence limits and comments on use. Am. J. Hum. Genet. 29 (1977) 94-97
37. The Italien Cooperative Study Group on chronic myeloid leukemia: Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N. Engl. J. Med. 330 (1994) 820-825
38. Kamada, N., H. Uchino: Chronologic sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia. Blood 51 (1978) 843-850
39. Kantarjian, H. M., M. Talpaz, D. Kontoyiannis, et al.: Treatment of chronic myelogenous leukemia in accelerated and blastic phases with Daunorubicin, high-dose Cytarabine, and Granulocyte-Macrophage Colony-Stimulating Factor. J. Clin. Oncol. 10 (1992) 398-105
40. Klingebiel, T., U. Creutzig, R. Dopfer, et al.: Bone marrow tranplantation in comparison with conventional therapy in children with adult type chronic myelogenous leukemia. Bone Marrow Transplant. 5 (1990) 317-320
41. Klingebiel, T.: Kooperatives pädiatrisches Knochenmarktransplantationsregister Österreich-Deutschland. Ergebnisse der Auswertung bis 31. März 1995. Univ. Kinderklinik Tübingen, Rümelinstr. 19-23, 72070 Tübingen, Tübingen 1995
42. Kolb, H. J., J. Mittermüller, C. Clemm, et al.: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76 (1990) 2462-2465
43. Lion, T., F. Prischl, O. A. Haas, et al.: Non-radioactive detection of the rearranged BCR/ABL sequences amplified by polymerase chain reaction. Leukemia 5 (1991) 156-159
44. Lion, T.: Clinical implications of qualitative and quantitative polymerase chain reaction analysis in the monitoring of patients with chronic myelogenous leukemia. Bone Marrow Transplant. 14 (1994) 505-509
45. Lion, T., A. Gaiger, T. Henn, E. Hörth, O. A. Haas, K. Geissler, H. Gadner: Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia 9 (1995) 1353-1360
46. Martelli, M. F., A. Tabilio, F. Falzetti, et al.: Successful engraftment of T-cell depleted haploidentical "three loci" incompatible transplants in leukemia patients by adding of peripheral blood progenitor cells to bone marrow inoculum. (Abstract) Acta Haematol. 93 (1995) 137
47. Minot, G. R., T. E. Buckman, R. Isaacs: Chronic myelogenous leukemia. Age, incidence and benefit derived from treatment. J. Am. Med. Ass. 82 (1924) 1489-1495
48. Mitelman, F.: The cytogenetic scenario of chronic myeloid leukemia. Leukemia Lymphoma 11 (Suppl. 1) (1993) 11-15
49. O'Brien, S. G., J. M. Goldman: Current approaches to hemopoietic stem cell purging in chronic myeloid leukemia. J. Clin. Oncol. 13 (1995) 541-546
50. Ozer, H., S. L. George, C. A. Schiffer, et al.: Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive, chronic phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and leukemia Study Group B Study 8583. Blood 82 (1993) 2975-2984
51. Porter, D. L., M. S. Roth, C. McGarigle, et al.: Induction of graft-versus host disease as immunotherapy for relapsed chronic myeloid leukemia. N. Engl. J. Med. 330 (1994) 100-106
52. Reiffers, J., J. M. Goldman, G. Meloni, et al.: Autologous transplantation in chronic myelogenous leukemia: European results. Bone Marrow Transplant. 14 Suppl 3 (1994) S51-S54
53. Russo, D., R. Fanin, E. Zuffa, et al.: Sequential Treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha. Haematologica (Pavia) 75 (1990) 334-339
54. Schreiner, T., M. Wiesneth, W. Friedrich, et al.: Allogeneic PBPC grafts for HLA-non-identical transplantation: combination of CD 34+-selection and T-cell depletion. (Abstract) J. Hematother. 4 (1995) 197
55. Schwinger, W., C. Urban, C. J. Mache, et al.: Adoptive immunotransfer with viable donor mononuclear cells for recurrent chronic myelogenous leukemia after allogeneic bone marrow transplantation in two children. Pediatr. Hematol. Oncol. 12 (1995) 47-54
56. Silberman, G., M. G. Crosse, E. A. Peterson, et al.: Availability and appropriateness of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries. N. Engl. J. Med. 331 (1994) 1063-1067
57. Simonsson, B., G. Oberg, A. Killander, et al.: Intensive treatment in order to minimze the Ph-positive clone in CML. Bone Marrow Transplant 14 (Suppl. 3) (1994) S55-S56
58. Snyder, D., R. S. Negrin, M. R. O'Donneli, et al.: Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase. Blood 84 (1994) 1672-1679
59. Storey, N., A. L. Lennard, A. M. Dickinson, et al.: Collection of BCR/ ABL negative peripheral blood progenitor cells in newly diagnosed patients with CML. (Abstract) Acta Haematol 93 (1995) 120
60. Talpaz, M., H. M. Kantarjian, K. McCredie, et al.: Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha in chronic myelogenous leukemia. N. Engl. J. Med. 314 (1986) 1065-1069
61. van Rhee, F., F. Lin, J. O. Cullis, et al.: Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematological relapse. Blood 83 (1994) 3377-3383
62. Verschraegen, C. F., M. Talpaz, C. F. Hirsch-Ginsberg, et al.: Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia. Blood 85 (1995) 2705-2710